Fulcrum Therapeutics, Inc. Profile Avatar - Palmy Investing

Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candida…

Biotechnology
US, Cambridge [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of FULC's Analysis
CIK: 1680581 CUSIP: 359616109 ISIN: US3596161097 LEI: - UEI: -
Secondary Listings
FULC has no secondary listings inside our databases.